2-Ethenyl-3-ethyl-5-methylpyrazine
Common Name: |
2-Ethenyl-3-ethyl-5-methylpyrazine |
IUPAC Name: |
2-ethenyl-3-ethyl-5-methylpyrazine |
Molecular Formula: |
C9H12N2 |
SMILES: |
CCC1=NC(=CN=C1C=C)C |
Inchi: |
1S/C9H12N2/c1-4-8-9(5-2)11-7(3)6-10-8/h4,6H,1,5H2,2-3H3 |
Inchi Key: |
YSQNQOKRWIKETP-UHFFFAOYSA-N |
Cas No: |
181589-32-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
148.20 |
Mass (g/mol) |
148.1 |
Molar Refractivity |
46.86 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
25.78 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
202.00 to 203.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.417 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
1.99 |
iLOGP |
2.14 |
XLOGP3 |
1.93 |
WLOGP |
1.88 |
MLOGP |
0.78 |
ESOL Log S |
-2.25 |
ESOL Solubility (mg/ml) |
0.84 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.10 |
Ali Solubility (mg/ml) |
1.19 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.26 |
Silicos-IT Solubility (mg/ml) |
0.08 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.83 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.626 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.372 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |